Related Experiment Video
Updated: Jun 12, 2026

ABCG5/G8 Crystallization in a Lipidic Bicelle Environment for X-Ray Crystallography
Published on: August 25, 2023
β-Cyclodextrin-chitosan based carriers enhance the solubility and dissolution of baicalein through inclusion complex
Ruba Malkawi1, Baraa Jarwan2, Maram B Alhawarri3
1School of Pharmacy, Jadara University, Irbid, Jordan. R.malkawi@Jadara.edu.jo.
None:
Baicalein (BA) is a poorly water-soluble flavonoid whose limited aqueous solubility restricts its oral bioavailability and pharmaceutical performance. This study aimed to enhance BA solubility and dissolution behavior through the development of binary (BA-β-cyclodextrin) and ternary (BA-β-cyclodextrin-chitosan) inclusion systems. Solid-state characterization was performed using DSC, FTIR and XRD analysis, while thermodynamic evaluation was conducted through Higuchi-Connors phase-solubility analysis. Molecular docking and MM-GBSA calculations were employed to support host-guest interaction mechanisms. Equilibrium solubility studies revealed that pure BA exhibited an intrinsic solubility of 7.50 µg/mL, whereas the optimized 1:2 BA:β-CD binary complex achieved 65.99 µg/mL, corresponding to approximately 8.8-fold enhancement. The phase-solubility diagram displayed an AL-type profile with a calculated apparent stability constant (K_s) of 5.3 × 102 M-1, confirming predominant 1:1 inclusion complex formation. Dissolution studies further demonstrated significantly improved cumulative drug release for binary systems and sustained-release behaviour for ternary complexes. These findings provide integrated thermodynamic, physicochemical, and computational evidence supporting cyclodextrin-assisted solubilization of baicalein and highlight the potential of combined inclusion-polymer systems for improving the pharmaceutical performance of poorly soluble flavonoids.
Related Concept Videos
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Site-Targeted Drug Delivery Systems: Polymeric Carriers
